These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 37581436)

  • 41. Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico.
    Paniagua-Contreras GL; Monroy-Pérez E; Bautista A; Reyes R; Vicente A; Vaca-Paniagua F; Díaz CE; Martínez S; Domínguez P; García LR; Uribe-García A; Vaca S
    Pathog Glob Health; 2018 Dec; 112(8):415-420. PubMed ID: 30433859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages.
    Biggel M; Xavier BB; Johnson JR; Nielsen KL; Frimodt-Møller N; Matheeussen V; Goossens H; Moons P; Van Puyvelde S
    Nat Commun; 2020 Nov; 11(1):5968. PubMed ID: 33235212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel chaperone-effector-immunity system identified in uropathogenic
    Casiano González A; Pacheco Villanueva A; Castro-Alarcón N; Méndez J; Oropeza R; Martínez-Santos VI
    PeerJ; 2024; 12():e17336. PubMed ID: 38784397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.
    Zhao F; Yang H; Bi D; Khaledi A; Qiao M
    Microb Pathog; 2020 Jul; 144():104196. PubMed ID: 32283258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries.
    Ramos NL; Dzung DT; Stopsack K; Jankó V; Pourshafie MR; Katouli M; Brauner A
    Eur J Clin Microbiol Infect Dis; 2011 Dec; 30(12):1587-93. PubMed ID: 21509475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
    Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
    Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics of Escherichia coli Urine Isolates and Risk Factors for Secondary Bloodstream Infections in Patients with Urinary Tract Infections.
    Choi HJ; Jeong SH; Shin KS; Kim YA; Kim YR; Kim HS; Shin JH; Shin JH; Uh Y; Bae S; Yoon EJ; Yoo JS
    Microbiol Spectr; 2022 Aug; 10(4):e0166022. PubMed ID: 35862950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uropathogenic Escherichia coli in Mexico, an Overview of Virulence and Resistance Determinants: Systematic Review and Meta-analysis.
    Ballesteros-Monrreal MG; Mendez-Pfeiffer P; Barrios-Villa E; Arenas-Hernández MMP; Enciso-Martínez Y; Sepúlveda-Moreno CO; Bolado-Martínez E; Valencia D
    Arch Med Res; 2023 Apr; 54(3):247-260. PubMed ID: 36725379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidrug resistance among uropathogenic clonal group A E. Coli isolates from Pakistani women with uncomplicated urinary tract infections.
    Khan A; Saraf VS; Siddiqui F; Batool T; Noreen Z; Javed S; Ahmad A; Alonazi WB; Ibrahim M; Pucciarelli S; Bokhari H
    BMC Microbiol; 2024 Mar; 24(1):74. PubMed ID: 38454332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome of acute urinary tract infections caused by uropathogenic
    Pullanhi U; Khan S; Vinod V; Mohan K; Kumar A
    Ann Afr Med; 2019; 18(3):138-142. PubMed ID: 31417014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergence of Enteroaggregative Escherichia coli within the ST131 Lineage as a Cause of Extraintestinal Infections.
    Boll EJ; Overballe-Petersen S; Hasman H; Roer L; Ng K; Scheutz F; Hammerum AM; Dungu A; Hansen F; Johannesen TB; Johnson A; Nair DT; Lilje B; Hansen DS; Krogfelt KA; Johnson TJ; Price LB; Johnson JR; Struve C; Olesen B; Stegger M
    mBio; 2020 May; 11(3):. PubMed ID: 32430467
    [No Abstract]   [Full Text] [Related]  

  • 52. Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group in uropathogenic Escherichia coli strains isolated from Korean patients.
    Hyun M; Lee JY; Kim HA
    Ann Clin Microbiol Antimicrob; 2021 Nov; 20(1):77. PubMed ID: 34758824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive phenotypic and genotypic characterization and comparison of virulence, biofilm, and antimicrobial resistance in urinary Escherichia coli isolated from canines.
    Gilbertie JM; Levent G; Norman KN; Vinasco J; Scott HM; Jacob ME
    Vet Microbiol; 2020 Oct; 249():108822. PubMed ID: 32937249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. UPEC strain characterization isolated from Mexican patients with recurrent urinary infections.
    Morales-Espinosa R; Hernandez-Castro R; Delgado G; Mendez JL; Navarro A; Manjarrez A; Cravioto A
    J Infect Dev Ctries; 2016 Apr; 10(4):317-28. PubMed ID: 27130992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.
    Michaud JE; Kim KS; Harty W; Kasprenski M; Wang MH
    BMC Microbiol; 2017 May; 17(1):127. PubMed ID: 28545489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance and virulence potential of uropathogenic Escherichia coli strains isolated from patients hospitalized in urology departments: a French prospective multicentre study.
    Lavigne JP; Bruyère F; Bernard L; Combescure C; Ronco E; Lanotte P; Coloby P; Thibault M; Cariou G; Desplaces N; Costa P; Sotto A
    J Med Microbiol; 2016 Jun; 65(6):530-537. PubMed ID: 26953145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole-genome sequencing of uropathogenic Escherichia coli reveals long evolutionary history of diversity and virulence.
    Lo Y; Zhang L; Foxman B; Zöllner S
    Infect Genet Evol; 2015 Aug; 34():244-50. PubMed ID: 26112070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Invasion and translocation of uropathogenic Escherichia coli isolated from urosepsis and patients with community-acquired urinary tract infection.
    Owrangi B; Masters N; Kuballa A; O'Dea C; Vollmerhausen TL; Katouli M
    Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):833-839. PubMed ID: 29340897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presence of fimH and iss type 1, 2 and 3 genes in uropathogenic Escherichia coli isolates recovered from an apex medical institute in North India.
    Bali N; Borkakoty B; Ali A; Ahmed T; Roohi S; Wani S; Nisar Q; Hazarika R
    Indian J Med Microbiol; 2023; 46():100417. PubMed ID: 37945109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist.
    Spaulding CN; Klein RD; Ruer S; Kau AL; Schreiber HL; Cusumano ZT; Dodson KW; Pinkner JS; Fremont DH; Janetka JW; Remaut H; Gordon JI; Hultgren SJ
    Nature; 2017 Jun; 546(7659):528-532. PubMed ID: 28614296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.